Bupropion Genericon 150 mg tablete s prilagođenim oslobađanjem
| Name | Bupropion Genericon 150 mg tablete s prilagođenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-109889434 |
| Active Substance | bupropionklorid |
| Composition | jedna tableta sadrži 150 mg bupropionklorida |
| Pharmaceutical Form | tableta s prilagođenim oslobađanjem |
| Manufacturer | Balkanpharma - Dupnitsa AD, Dupnitsa, Bugarska Genericon Pharma Gesellschaft m.b.H., Graz, Austrija |
| Marketing Authorisation Holder | Genericon Pharma Gesellschaft m.b.H., Hafnerstraße 211, Graz, Austrija |
| Marketing Authorisation Date | 09.07.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/24-02/04 |
| Registration Number | 381-12-01/70-24-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N06AX12 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
